Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch
VANCOUVER, BC--(Marketwired - January 09, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), announced today that it has received approval from Health Canada to initiate a multi-dose Proof …